Ms. Nadiah Wan, aged 34, was appointed as Chief Executive Officer of Thomson Hospitals Sdn Bhd and Group Chief Corporate Officer of TMC Life Sciences Berhad on 19 June 2017.
Prior to joining Thomson Hospitals Sdn Bhd and the Company, Ms. Nadiah Wan worked in Sunway Medical Centre as Chief Operating Officer (Clinical Services) after being promoted from Director of Business Development and Corporate Communications in October 2016. She started her career at The Boston Consulting Group in 2007 as an Associate Consultant before joining Sunway Group as Manager, Strategy and Corporate Development in 2010.
Ms. Nadiah Wan holds MSc Public Health Nutrition degree qualification from the London School of Hygiene and Tropical Medicine, UK and an AB cum Laude in Biochemical Sciences from Harvard College. She also serves as an Interviewer for Harvard College admissions and is an Exco member of the Harvard Club of Malaysia.
Ms. Nadiah Wan does not hold any directorship in other public companies and listed issuer in Malaysia. She has no family relationship with any Director and/or major shareholder of the Company. She has no convictions of any offences within the past five (5) years and has no public sanctions and/or penalties imposed by the relevant regulatory bodies during the financial year. Also, she has no conflict of interest with the Company.
Mr. Wong Yu Chee has over 22 years’ experience in finance, audit, accounting and tax compliance services in Malaysia and Shanghai. Mr. Wong started his career in 1996 joining a local audit firm as auditor. He then joined Coopers & Lybrand in 1997, now known as PricewaterhouseCoopers (PwC). Mr. Wong spent 8 years in PwC specialised in assurance assignment of large multinational company, public listed companies in various industries, IPO and corporate exercise.
Mr. Wong joined GlaxoSmithKline then as Finance Manager before he left Malaysia joining Ernst & Young Shanghai end 2005. Mr. Wong spent 3 years in Ernst & Young Shanghai focusing on statutory audit assignment, IPO assurance assignment, corporate exercise and US audit assignment until he joined TMF Shanghai end 2008, leading the accounting and tax compliance services in TMF Shanghai for 2 years. Mr. Wong relocated back to Malaysia in 2010, as Director of Accounting & Tax Compliance Services in TMF Malaysia where he spent 5 years helping businesses on accounting and tax compliance including GST advisory and compliance services.
Mr. Wong then joined PCA Corporate Services Sdn Bhd in 2015 as Group Chief Operating Officer before joining TMC Life Sciences Berhad as Group Chief Financial Officer on 3 August 2015. Mr. Wong is a Fellow Member of Association of Chartered Certified Accountants (FCCA), member of Malaysian Institute of Accountants (MIA)-Chartered Accountant (M) and Associate Member of Chartered Tax Institute of Malaysia (ACTIM).
Mr. Wong does not hold any directorship in other public companies and listed issuer in Malaysia. He has no family relationship with any Director and/or major shareholder of the Company. He has no convictions of any offences within the past five (5) years and has no public sanctions and/or penalties imposed by the relevant regulatory bodies during the financial year. Also, he has no conflict of interest with the Company.
Ms Irene Kwan Yee Man joined the team as the Chief Executive Officer of TMC Women’s Specialist Holdings Sdn Bhd, IVF Technologies Sdn Bhd, Thomson TCM Sdn Bhd, TMC Biotech Sdn Bhd, and TMC Care Sdn Bhd in August 2019.
With 20 years of vast experience in pharmaceutical and medical industries, she has played crucial roles in corporate management, business development and expansion across Malaysia and globally.
In 1999, as the Senior Pharmacist, she managed the Outpatient Pharmacy, Inpatient Pharmacy and Cytotoxic Drug Reconstitution Unit in Subang Jaya Medical Centre. She then moved on to Diethelm Malaysia and managed key principal accounts for supply chain of pharmaceuticals and vaccines. She also managed key accounts in B Braun Medical Supplies.
Subsequently in 2006, she ventured into the beauty and wellness business, building the business and operations. In 2009, she took on an active and critical role as the Pharmacy Manager in Assunta Hospital.
In 2016, she was appointed as Business Development Director of an IT healthcare software company. In 2018, she was Chief Operating Officer of an IT project management company in Malaysia handling projects within South East Asia.
Ms Irene Kwan holds a degree in Pharmacy from Liverpool John Moores University in UK. She is also a member of Malaysian Pharmacy Board and a Licensed Pharmacist.
Ms Irene Kwan does not hold any directorship in other public companies and listed issuer in Malaysia. She has no family relationships with any Director and/or major shareholders of the Company. She has no convictions of any offences within the past five (5) years and has no public sanctions and/or penalties imposed by the relevant regulatory bodies during the financial year. Also, she has no conflicts of interest with the Company.